Prospective validation of initial eculizumab dosing in adults with atypical hemolytic uremic syndrome

Nephrol Dial Transplant. 2025 Feb 28;40(3):598-601. doi: 10.1093/ndt/gfae244.

CUREiHUS study group:
R de Wildt, W Altena, K Wijnsma, L Ter Steeg, A D van Zuilen, M Eijgelsheim, F J Bemelman, D Severs, E Bredewold, S Timmermans, P van Paassen, J F M Wetzels, W A G van der Meijden, A E van de Logt, J A E van Wijk, A H M Bouts, E M Dorresteijn, V Gracchi, F A P T Engels, M G Keijzer-Veen, R W G van Rooij

¹ Department of Pharmacy, Radboud University Medical Center, Nijmegen, Netherlands.
² Department of Nephrology, Radboud University Medical Center, Nijmegen, Netherlands.
³ Department of Pediatric Nephrology, Amalia Children's Hospital, Radboud University Medical Center, Nijmegen, Netherlands.
⁴ Department of Laboratory Medicine, Radboud University Medical Center, Nijmegen, Netherlands.
⁵ Department of Pediatrics/Pediatric Nephrology, University Hospitals Leuven, Leuven, Belgium.
⁶ Department of Development and Regeneration, University Hospitals Leuven, Leuven, Belgium.
⁷ Department of Hematology, Radboud University Medical Center, Nijmegen, Netherlands.

No abstract available

Grants and funding